SOLCO HEALTHCARE US supplier risk profile Q1-2026: import analysis, compliance flags, China sourcing
SOLCO HEALTHCARE US imported 104 shipments in Q1 2026 from 2 suppliers across 1 country. China accounted for 100% of shipments. The company's imports fall under HS Chapter 30 (Pharmaceutical Products), with the primary supplier being Zhejiang Huahai Pharmaceutical, which originated 103 of the 104 shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
SOLCO HEALTHCARE US registered zero sanctions watchlist matches in Q1 2026. None of the company's suppliers show documented forced-labor exposure under UFLPA mapping.
2 distinct tier-1 suppliers in Q1 2026
| ZHEJIANG HUAHAI PHARMACEUTICAL | China | 103 |
| ZHEJIANG HUAHAI PHARMACEUTICAL TECH | China | 1 |
Share of Q1 2026 inbound shipments by source country
3 tier-2 + 1 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.